Comparison of Actifuse ABX and Local Bone in Spinal Surgery
Scoliosis, Kyphosis, Lordosis
About this trial
This is an interventional treatment trial for Scoliosis focused on measuring Spinal Deformity, Multilevel, Posterior, Lumbar, Fusion, Levoscoliosis, Dextroscoliosis, Graft
Eligibility Criteria
Inclusion Criteria:
- Patient aged 18 to 80
- Patient received primary diagnosis of adult spinal deformity (with fusion of >2 levels)
- Patient is a candidate for multi-level posterior lumbar fusion
- Patients that do not meet any of the exclusion criteria
Exclusion Criteria:
- Non-English speaker
- Current Smoker
- Prisoner
- Patient with any of the following:
Severe degenerative disease Inflammatory bone disease (e.g. osteomyelitis) Metabolic bone disease Radiation bone therapy Existing acute or chronic infections Abnormal calcium metabolism Hypocalcaemia Severe vascular or neurological disease Cardiovascular disease precluding elective surgery Uncontrolled diabetes Severely impaired renal function Documented renal disease Malignant tumors Pregnant or nursing
Sites / Locations
- The Ohio State University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Multilevel Spinal Fusion w/ Actifuse ABX®
Multilevel Spinal Fusion
An osteostimulatory,phase pure,porous,silicate substituted calcium phosphate bone graft substitute used during multilevel spinal fusion.
Multilevel spinal fusion without Actifuse ABX.